Why is gold breaking out?

From Mineral Stock News | Ad

Gold's on pace to smash its records. This miner's potential is jaw dropping.

See this gold miner immediately

ITCI Insider Trading (Intra-Cellular Therapies)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,316,864.43

Intra-Cellular Therapies Insider Trading History Chart

Intra-Cellular Therapies Share Price & Price History

^$36.64

▼ -1.32 (-3.48%)

As of 09/24/2021 03:52 PM ET

Days: 30 | 90 | 365

Hottest Stock Pick for 2021

From Emerging Markets Consulting | Ad

This could be the most underrated stock available. Watch it closely.

Click here to learn more

Intra-Cellular Therapies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2021	Joel S. Marcus	Director	Sell	18,289	$42.27	$773,076.03	13,767
5/27/2021	Christopher D. Alafi	Director	Sell	8,482	$40.01	$339,364.82	346,795
5/24/2021	Christopher D. Alafi	Director	Sell	26,575	$40.47	$1,075,490.25	346,795
5/21/2021	Christopher D. Alafi	Director	Sell	1,100	$40.00	$44,000.00	346,795
2/19/2021	Lawrence J Hineline	CFO	Sell	10,442	$39.23	$409,639.66	10,442
2/19/2021	Mark Neumann	EVP	Sell	5,184	$39.22	$203,316.48	50,523
2/19/2021	Sharon Mates	CEO	Sell	27,847	$39.23	$1,092,437.81	1,161,239
2/19/2021	Suresh K Durgam	Insider	Sell	2,734	$39.25	$107,309.50	25,838
1/11/2021	Lawrence J. Hineline	CFO	Sell	19,638	$32.02	$628,808.76
1/11/2021	Mark Neumann	EVP	Sell	9,684	$32.02	$310,081.68	49,068
1/11/2021	Sharon Mates	CEO	Sell	41,896	$32.01	$1,341,090.96	1,175,288
1/11/2021	Suresh K Durgam	Insider	Sell	4,367	$32.12	$140,268.04	21,851
1/4/2021	Lawrence J Hineline	CFO	Sell	15,810	$31.31	$495,011.10
1/4/2021	Michael Halstead	EVP	Sell	16,160	$31.30	$505,808.00
1/4/2021	Sharon Mates	CEO	Sell	48,341	$31.30	$1,513,073.30
11/17/2020	Michael Halstead	EVP	Sell	79,425	$27.62	$2,193,718.50	79,425
11/11/2020	Lawrence J Hineline	CFO	Sell	28,034	$25.41	$712,343.94	18,034
11/4/2020	Sharon Mates	CEO	Sell	50,000	$25.00	$1,250,000.00	1,163,392
10/16/2020	Mark Neumann	EVP	Sell	6,792	$26.80	$182,025.60	34,912
9/14/2020	Christopher D. Alafi	Director	Buy	49,500	$29.60	$1,465,200.00	345,223
9/11/2020	Christopher D. Alafi	Director	Buy	21,000	$28.08	$589,680.00
9/9/2020	Lawrence J Hineline	CFO	Sell	41,983	$31.14	$1,307,350.62	50,017
5/13/2020	Joel S. Marcus	Director	Sell	7,297	$20.63	$150,537.11	14,374
5/11/2020	Joel S. Marcus	Director	Sell	50,000	$19.95	$997,500.00	14,374
1/9/2020	Andrew Satlin	EVP	Sell	11,573	$26.16	$302,749.68	22,911
1/9/2020	Lawrence J Hineline	CFO	Sell	19,638	$26.16	$513,730.08	18,800
1/9/2020	Sharon Mates	CEO	Sell	41,895	$26.16	$1,095,973.20	1,204,707
1/6/2020	Michael Halstead	EVP	Sell	21,458	$30.34	$651,035.72	17,704
1/6/2020	Sharon Mates	CEO	Sell	45,598	$30.28	$1,380,707.44	1,182,366
1/2/2020	Michael Halstead	EVP	Sell	7,807	$32.43	$253,181.01	7,998
1/2/2020	Sharon Mates	CEO	Sell	17,478	$32.45	$567,161.10	1,156,185
10/16/2019	Mark Neumann	EVP	Sell	6,774	$8.25	$55,885.50	13,448
9/10/2019	Christopher D. Alafi	Director	Buy	485,000	$10.26	$4,976,100.00	341,223
8/30/2019	Christopher D. Alafi	Director	Buy	125,000	$8.52	$1,065,000.00	341,223
6/12/2019	Christopher D. Alafi	Director	Buy	170,000	$11.73	$1,994,100.00	750,106
5/14/2019	Christopher D. Alafi	Director	Buy	100,000	$12.56	$1,256,000.00	750,106
2/27/2019	Lawrence J Hineline	CFO	Sell	1,000	$15.00	$15,000.00	25,832
1/7/2019	Kimberly E Vanover	SVP	Sell	592	$12.29	$7,275.68	37,224
1/7/2019	Michael Halstead	EVP	Sell	3,108	$12.42	$38,601.36	24,757
1/7/2019	Sharon Mates	CEO	Sell	6,604	$12.43	$82,087.72	1,190,909
1/4/2019	Kimberly E Vanover	SVP	Sell	9,564	$11.47	$109,699.08	37,224
1/4/2019	Michael Halstead	EVP	Sell	21,458	$11.46	$245,908.68	24,757
1/4/2019	Sharon Mates	CEO	Sell	45,598	$11.45	$522,097.10	1,190,909
1/2/2019	Lawrence J Hineline	SVP	Sell	7,807	$11.09	$86,579.63	24,839
1/2/2019	Sharon Mates	CEO	Sell	17,478	$11.09	$193,831.02	1,156,185
12/6/2018	Robert E Davis	SVP	Sell	899	$13.53	$12,163.47	31,155
11/12/2018	Joel S. Marcus	Director	Sell	32,000	$18.17	$581,440.00	21,671
11/9/2018	Joel S. Marcus	Director	Sell	25,000	$18.24	$456,000.00	21,671

Insider Trading at Intra-Cellular Therapies?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Intra-Cellular Therapies and related companies.

SEC Filings (Institutional Ownership Changes) for Intra-Cellular Therapies (NASDAQ:ITCI)

81.80% of Intra-Cellular Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Intra-Cellular Therapies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/17/2021	Virtu Financial LLC	9,780	$0.40M	0.0%	N/A	0.012%
9/3/2021	Parametric Portfolio Associates LLC	235,871	$9.63M	0.0%	+101.9%	0.290%
8/30/2021	B. Metzler seel. Sohn & Co. Holding AG	19,754	$0.81M	0.0%	-10.8%	0.024%
8/23/2021	Morgan Stanley	663,263	$27.07M	0.0%	+51.4%	0.815%
8/17/2021	Wells Fargo & Company MN	54,862	$2.24M	0.0%	-10.8%	0.067%
8/17/2021	Walleye Capital LLC	87,653	$3.58M	0.1%	+36.8%	0.108%
8/17/2021	Weiss Multi Strategy Advisers LLC	20,789	$0.85M	0.0%	+3.7%	0.026%
8/17/2021	Invesco Ltd.	253,678	$10.36M	0.0%	-16.3%	0.312%
8/17/2021	Maverick Capital Ltd.	9,462	$0.39M	0.0%	N/A	0.012%
8/17/2021	Metropolitan Life Insurance Co NY	19,527	$0.80M	0.0%	+108,383.3%	0.024%
8/17/2021	Millennium Management LLC	642,978	$26.25M	0.0%	-19.4%	0.790%
8/17/2021	Price T Rowe Associates Inc. MD	36,243	$1.48M	0.0%	-10.0%	0.045%
8/17/2021	Prudential Financial Inc.	54,647	$2.23M	0.0%	N/A	0.067%
8/16/2021	Squarepoint Ops LLC	8,198	$0.34M	0.0%	N/A	0.010%
8/16/2021	AQR Capital Management LLC	8,522	$0.35M	0.0%	-53.7%	0.010%
8/16/2021	Bank of America Corp DE	87,030	$3.55M	0.0%	-60.9%	0.107%
8/16/2021	Amalgamated Bank	13,346	$0.55M	0.0%	+93.3%	0.016%
8/16/2021	UBS Asset Management Americas Inc.	79,901	$3.26M	0.0%	+18.9%	0.098%
8/16/2021	FORA Capital LLC	1,425	$58K	0.0%	N/A	0.002%
8/16/2021	Cubist Systematic Strategies LLC	16,124	$0.66M	0.0%	+200.7%	0.020%
8/16/2021	California State Teachers Retirement System	97,406	$3.98M	0.0%	-2.6%	0.120%
8/16/2021	Tri Locum Partners LP	150,783	$6.16M	2.0%	N/A	0.185%
8/16/2021	First Trust Advisors LP	52,003	$2.12M	0.0%	N/A	0.064%
8/16/2021	Royal Bank of Canada	19,419	$0.79M	0.0%	+39.4%	0.024%
8/16/2021	Morgan Stanley	663,263	$27.07M	0.0%	+51.4%	0.815%
8/16/2021	Credit Suisse AG	47,706	$1.95M	0.0%	-8.4%	0.059%
8/16/2021	Schonfeld Strategic Advisors LLC	10,241	$0.42M	0.0%	N/A	0.013%
8/16/2021	Maven Securities LTD	5,100	$0.21M	0.0%	N/A	0.006%
8/16/2021	Charles Schwab Investment Management Inc.	491,013	$20.04M	0.0%	+3.3%	0.604%
8/16/2021	Premier Asset Management LLC	42,611	$1.74M	0.3%	+242.0%	0.052%
8/16/2021	State Street Corp	1,500,029	$61.23M	0.0%	+1.1%	1.844%
8/16/2021	Nuveen Asset Management LLC	694,758	$28.36M	0.0%	-8.8%	0.854%
8/16/2021	Goldman Sachs Group Inc.	734,616	$29.99M	0.0%	-10.1%	0.903%
8/16/2021	Macquarie Group Ltd.	451,441	$18.43M	0.0%	-0.2%	0.555%
8/16/2021	Marshall Wace LLP	2,771,304	$113.13M	0.5%	-2.2%	3.407%
8/16/2021	Allianz Asset Management GmbH	18,250	$0.75M	0.0%	-40.9%	0.022%
8/13/2021	Northern Trust Corp	857,660	$35.01M	0.0%	+4.0%	1.054%
8/13/2021	Tekla Capital Management LLC	202,756	$8.28M	0.3%	-12.8%	0.250%
8/13/2021	Clearbridge Investments LLC	473,393	$19.32M	0.0%	-0.4%	0.583%
8/13/2021	Brandywine Global Investment Management LLC	195,560	$7.98M	0.1%	N/A	0.241%
8/13/2021	LPL Financial LLC	14,526	$0.59M	0.0%	+6.1%	0.018%
8/13/2021	Franklin Resources Inc.	1,364,652	$55.71M	0.0%	+16.8%	1.681%
8/13/2021	Stifel Financial Corp	39,770	$1.62M	0.0%	-1.1%	0.049%
8/13/2021	DCF Advisers LLC	375,000	$15.31M	5.4%	-11.7%	0.462%
8/13/2021	Qube Research & Technologies Ltd	10,046	$0.41M	0.0%	-56.6%	0.012%
8/13/2021	Geode Capital Management LLC	1,253,202	$51.16M	0.0%	+4.9%	1.543%
8/13/2021	Vanguard Group Inc.	6,828,437	$278.74M	0.0%	+1.6%	8.409%
8/13/2021	FMR LLC	12,122,894	$494.86M	0.0%	-0.1%	14.929%
8/13/2021	Rhenman & Partners Asset Management AB	429,728	$17.54M	1.2%	-6.1%	0.529%
8/13/2021	ProShare Advisors LLC	32,924	$1.34M	0.0%	+13.8%	0.041%
8/13/2021	EAM Investors LLC	48,220	$1.97M	0.3%	N/A	0.059%
8/12/2021	Wasatch Advisors Inc.	6,506,789	$265.61M	1.1%	-0.3%	8.013%
8/12/2021	Trexquant Investment LP	15,366	$0.63M	0.1%	N/A	0.019%
8/12/2021	Profund Advisors LLC	7,321	$0.30M	0.0%	+9.6%	0.009%
8/12/2021	AlphaCrest Capital Management LLC	5,200	$0.21M	0.0%	N/A	0.006%
8/12/2021	Dimensional Fund Advisors LP	607,434	$24.79M	0.0%	-22.4%	0.748%
8/12/2021	SG Americas Securities LLC	20,418	$0.83M	0.0%	+36.8%	0.025%
8/12/2021	Advisory Services Network LLC	775	$32K	0.0%	N/A	0.001%
8/12/2021	JPMorgan Chase & Co.	144,094	$5.88M	0.0%	-3.6%	0.177%
8/12/2021	Bank of Montreal Can	288,849	$11.64M	0.0%	+29.1%	0.356%
8/12/2021	Bellevue Group AG	3,609,919	$147.36M	1.4%	-1.4%	4.446%
8/12/2021	The Manufacturers Life Insurance Company	38,312	$1.56M	0.0%	+6.5%	0.047%
8/11/2021	Great West Life Assurance Co. Can	4,074	$0.17M	0.0%	-18.9%	0.005%
8/11/2021	Bank of New York Mellon Corp	331,744	$13.54M	0.0%	+8.8%	0.409%
8/11/2021	BlackRock Inc.	5,718,849	$233.44M	0.0%	-7.1%	7.043%
8/11/2021	Deutsche Bank AG	152,474	$6.23M	0.0%	+225.6%	0.188%
8/11/2021	Lord Abbett & CO. LLC	2,145,588	$87.58M	0.2%	+1.1%	2.642%
8/10/2021	Virtus ETF Advisers LLC	11,679	$0.48M	0.2%	-52.8%	0.014%
8/10/2021	Nicholas Investment Partners LP	598,261	$24.42M	1.5%	+7.9%	0.737%
8/10/2021	Principal Financial Group Inc.	29,980	$1.22M	0.0%	+21.8%	0.037%
8/10/2021	Skandinaviska Enskilda Banken AB publ	292,463	$11.94M	0.1%	+1,037.0%	0.360%
8/10/2021	BNP Paribas Arbitrage SA	2,648	$0.11M	0.0%	-87.0%	0.003%
8/10/2021	State Board of Administration of Florida Retirement System	27,253	$1.11M	0.0%	+5.8%	0.034%
8/10/2021	Citigroup Inc.	49,349	$2.01M	0.0%	+48.2%	0.061%
8/10/2021	WINTON GROUP Ltd	6,853	$0.28M	0.0%	-36.6%	0.008%
8/9/2021	TimesSquare Capital Management LLC	1,153,380	$47.08M	0.4%	-6.0%	1.420%
8/9/2021	Jaffetilchin Investment Partners LLC	90,938	$3.32M	0.2%	+107.9%	0.112%
8/9/2021	Meeder Asset Management Inc.	1,700	$69K	0.0%	N/A	0.002%
8/6/2021	Van Hulzen Asset Management LLC	9,000	$0.37M	0.1%	-8.2%	0.011%
8/6/2021	Asset Management Corp IL ADV	19,185	$0.78M	0.4%	-11.5%	0.024%
8/6/2021	Sei Investments Co.	46,209	$1.89M	0.0%	+164.5%	0.057%
8/6/2021	PNC Financial Services Group Inc.	2,096	$86K	0.0%	-13.3%	0.003%
8/6/2021	Swiss National Bank	151,600	$6.19M	0.0%	-8.0%	0.187%
8/6/2021	Fifth Third Bancorp	3,233	$0.13M	0.0%	N/A	0.004%
8/6/2021	St. Louis Trust Co	5,000	$0.20M	0.1%	N/A	0.006%
8/5/2021	General American Investors Co. Inc.	350,804	$14.32M	1.2%	+1.0%	0.432%
8/5/2021	American Century Companies Inc.	7,918	$0.32M	0.0%	N/A	0.010%
8/5/2021	Legato Capital Management LLC	10,270	$0.42M	0.1%	N/A	0.013%
8/5/2021	Rhumbline Advisers	73,866	$3.02M	0.0%	-21.4%	0.091%
8/5/2021	Teacher Retirement System of Texas	8,739	$0.36M	0.0%	+19.3%	0.011%
8/5/2021	Sargent Investment Group LLC	5,073	$0.21M	0.0%	N/A	0.006%
8/4/2021	Cooper Haims Advisors LLC	61,116	$2.50M	1.6%	N/A	0.075%
8/4/2021	Russell Investments Group Ltd.	272,321	$11.11M	0.0%	+2,756.3%	0.335%
8/3/2021	Avestar Capital LLC	26,097	$1.07M	0.1%	+22.4%	0.032%
8/3/2021	Handelsbanken Fonder AB	15,400	$0.63M	0.0%	+35.1%	0.019%
8/3/2021	Hussman Strategic Advisors Inc.	31,000	$1.27M	0.3%	N/A	0.038%
8/2/2021	Arizona State Retirement System	18,696	$0.76M	0.0%	-11.0%	0.023%
8/2/2021	New York State Common Retirement Fund	92,859	$3.79M	0.0%	+17.9%	0.114%
8/2/2021	Advisor Group Holdings Inc.	1,106	$45K	0.0%	+55.6%	0.001%
8/2/2021	Pinnacle Associates Ltd.	225,498	$9.21M	0.2%	+1.3%	0.278%

Data available starting January 2016

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. The firm's lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates on August 29, 2013 and is headquartered in New York, NY.

Today's Range

Now: $36.64

$36.30

$37.69

50 Day Range

MA: $33.42

$28.72

$37.96

52 Week Range

Now: $36.64

$22.92

$44.80

Volume

8,895 shs

Average Volume

532,018 shs

Market Capitalization

$2.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Intra-Cellular Therapies?: Intra-Cellular Therapies' top insider shareholders include:
Sharon Mates (CEO)
Christopher D Alafi (Director)
Michael Halstead (EVP)
Mark Neumann (EVP)
Lawrence J Hineline (CFO)
Suresh K Durgam (Insider)
Andrew Satlin (EVP)
Joel S Marcus (Director)
Lawrence J Hineline (CFO)
Who are the major institutional investors of Intra-Cellular Therapies?: Intra-Cellular Therapies' top institutional shareholders include:
FMR LLC — 14.93%
Vanguard Group Inc. — 8.41%
Wasatch Advisors Inc. — 8.01%
BlackRock Inc. — 7.04%
Bellevue Group AG — 4.45%
Marshall Wace LLP — 3.41%
Which institutional investors are selling Intra-Cellular Therapies stock?: In the previous quarter, ITCI stock was sold by these institutional investors:
BlackRock Inc.
Dimensional Fund Advisors LP
Susquehanna International Group LLP
Millennium Management LLC
Bank of America Corp DE
Goldman Sachs Group Inc.
TimesSquare Capital Management LLC
Nuveen Asset Management LLC
During the last year, company insiders that have sold Intra-Cellular Therapies company stock include:
Sharon Mates (CEO)
Christopher D Alafi (Director)
Michael Halstead (EVP)
Mark Neumann (EVP)
Lawrence J Hineline (CFO)
Suresh K Durgam (Insider)
Andrew Satlin (EVP)
Joel S Marcus (Director)
Which institutional investors are buying Intra-Cellular Therapies stock?: During the last quarter, ITCI stock was acquired by institutional investors including:
Skandinaviska Enskilda Banken AB publ
Russell Investments Group Ltd.
Morgan Stanley
Morgan Stanley
Franklin Resources Inc.
Brandywine Global Investment Management LLC
Tri Locum Partners LP
Parametric Portfolio Associates LLC